Evaluation of Drug Use in Gastroesophageal Reflux Disease (GERD) Patient at the Outpatient Installation
Keywords:
Evaluation of Drug Use, GERD, Patient
Abstract
Gastroesophageal Reflux Disease (GERD) is a disorder in which stomach contents reflux repeatedly into the esophagus, causing disturbing symptoms or complications. Heartburn and regurgitation are the hallmark symptoms of GERD. This study aims to determine the evaluation of drug use which includes the right indication, the right dose, the right drug and the right interval. The subjects in this study were GERD patients who met the inclusion criteria and were determined based on the slovin formula. The research method used is observational with a cross-sectional approach with a purposive sampling technique where this study describes and examines drug use in GERD patients at Aulia Hospital Pekanbaru in 2022. The results show drug use in GERD patients at the Outpatient Installation at Aulia Hospital Pekanbaru namely 100% right indication, 100% right dose, 100% right drug, and 100% right interval.
References
[1] Dewa, Gusti W. N., Ketut, P., Mariadi, Gde S.M., Good Clinical Pratctice:Update Understanding On Gastroenterology and Hepatology, Denpasar, 2017.
[2] Tandarto K. “Diagnosis Dan Tatalaksana Gastroesophageal Reflux Disease (Gerd) pada Fasilitas Kesehatan Tingkat Pertama”, Internal Medicnei, 2022.
[3] Hunt, Richard et al., “World Gastroenterology Organisation Global Guidelines”, Journal of Clinical Gastroenterology, vol. 51, No. 6, pp. 467–78, 2017.
[4] Hidayati, P.H., Syamsu, R.F., Safitri, A., Nurfachanti, Yusufputra, A. A. “Hubungan Body Mass Index (BMI) Terhadap Kejadian Gastroesophageal Reflux Disease ( GERD )”, Jurnal Kesehatan, vol. 5, no. 2. 2022.
[5] Barnhart, Douglas C, “Gastroesophageal Reflux Disease in Children”, Seminars in Pediatric Surgery, vol 25, no. 4, pp. 212–218, 2016.
[6] Kementerian Kesehatan Republik Indonesia, Farmasi Rumah Sakit Dan Klinik. 1st ed. Indonesia, Jakarta: Kemenkes RI, 2016.
[7] Patala, R., Tandi, J., Ulzmi, U., Fahruddin, “Rasionalitas Penggunanaan Obat Pada.Pasien GERD Di Instalasi Rawat Inap Rumah Sakit Umum Anutapura Palu”, JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2021.
[8] Aisiyah, N., Yuswar, A. M., Purwanti, U. N., “Rasionalitas Penggunaan Obat Pada Pasien GERD Di Instalasi Rawat Jalan Rumah Sakit”, Journal Syifa Sciences and Clinical Research (JSSCR), 2022.
[9] Dipiro.J.T., Pharmacotherapy Handbook 11th edition, Mc Graw Hill, New York, 475-281, 2021.
[10] Kim O, Hee JJ, Kim S, Hea YL, Eunyoung C, Jung EL, Heeja J, Jiyoung K., “Gastroesophageal Reflux Disease and Its Related Factors among Women of Reproductive Age: Korea Nurses’ Health Study”, BMC Public Health, 2018.
[11] Kartikasari, D., Administrasi Rumah Sakit, Malang: Penerbit Wineka Media, 2019.
[12] Rahman, A.A., Maulidina, W., Kokasih, E.D., “Gambaran Terapi Awal Pada Pasien GERD (Gastroesophageal Reflux Disease) Di Poliklinik Penyakit Dalam RSUD Dr. Soekardjo”. Jurnal Kesehatan Poltekes Kemenkes RI Pangkal Pinang, 2018
[13] Ndraha, S., Donny, O., Fransisca, Julian, L.S., Ni N. J., Marcel R., “Artikel Penelitian Faktor-Faktor yang berhubungan dengan Keberhasilan Terapi GERD”, Journal Kedokteran Meditek, 2019.
[14] Ikatan Apoteker Indonesia, ISO Informasi Spesialite Obat Indonesia, Volume 52, Jakarta: PTISFI Penerbitan, 2019.
[15] BNF, British National Formulary 84th Edition, London: BMJ Publishing Group, 2023.
[16] Surya, H., “Tatalaksana Gastroesofageal Reflux Disease (GERD) dalam Masa Pandemi COVID-19”, Medicinus, vol. 33, no. 3, pp. 74–80, 2020.
[17] Pulungan, R., Chan, A., Fransiska, E., “Evaluasi Penggunaan Obat Rasional di Puskesmas Kabupaten Serdang Bedagai”, Jurnal Dunia Farmasi, 2019.
[18] Patala, R., Tandi, J., Ulzmi, U., Fahruddin. “Rasionalitas Penggunanaan Obat pada Pasien GERD di Instalasi Rawat Inap Rumah Sakit Umum Anutapura Palu”, JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2021.
[19] Naomi, D.A. “Obesity as Risk Factor of Gastroesophageal Reflux Disease”, Refluks Gastroesofageal Journal MAJORITY, vol. 13, no. 7, 2014.
[20] Hafizh, S. M., Debi, M. L., “Hubungan Gastroesophageal Reflux Disease dengan Kualitas Tidur pada Mahasiswa Fakultas Kedokteran Universitas Muhammadiyah Sumatera Utara”, Jurnal Ilmiah MAKSITEK, vol. 6, No. 2, 2021.
[2] Tandarto K. “Diagnosis Dan Tatalaksana Gastroesophageal Reflux Disease (Gerd) pada Fasilitas Kesehatan Tingkat Pertama”, Internal Medicnei, 2022.
[3] Hunt, Richard et al., “World Gastroenterology Organisation Global Guidelines”, Journal of Clinical Gastroenterology, vol. 51, No. 6, pp. 467–78, 2017.
[4] Hidayati, P.H., Syamsu, R.F., Safitri, A., Nurfachanti, Yusufputra, A. A. “Hubungan Body Mass Index (BMI) Terhadap Kejadian Gastroesophageal Reflux Disease ( GERD )”, Jurnal Kesehatan, vol. 5, no. 2. 2022.
[5] Barnhart, Douglas C, “Gastroesophageal Reflux Disease in Children”, Seminars in Pediatric Surgery, vol 25, no. 4, pp. 212–218, 2016.
[6] Kementerian Kesehatan Republik Indonesia, Farmasi Rumah Sakit Dan Klinik. 1st ed. Indonesia, Jakarta: Kemenkes RI, 2016.
[7] Patala, R., Tandi, J., Ulzmi, U., Fahruddin, “Rasionalitas Penggunanaan Obat Pada.Pasien GERD Di Instalasi Rawat Inap Rumah Sakit Umum Anutapura Palu”, JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2021.
[8] Aisiyah, N., Yuswar, A. M., Purwanti, U. N., “Rasionalitas Penggunaan Obat Pada Pasien GERD Di Instalasi Rawat Jalan Rumah Sakit”, Journal Syifa Sciences and Clinical Research (JSSCR), 2022.
[9] Dipiro.J.T., Pharmacotherapy Handbook 11th edition, Mc Graw Hill, New York, 475-281, 2021.
[10] Kim O, Hee JJ, Kim S, Hea YL, Eunyoung C, Jung EL, Heeja J, Jiyoung K., “Gastroesophageal Reflux Disease and Its Related Factors among Women of Reproductive Age: Korea Nurses’ Health Study”, BMC Public Health, 2018.
[11] Kartikasari, D., Administrasi Rumah Sakit, Malang: Penerbit Wineka Media, 2019.
[12] Rahman, A.A., Maulidina, W., Kokasih, E.D., “Gambaran Terapi Awal Pada Pasien GERD (Gastroesophageal Reflux Disease) Di Poliklinik Penyakit Dalam RSUD Dr. Soekardjo”. Jurnal Kesehatan Poltekes Kemenkes RI Pangkal Pinang, 2018
[13] Ndraha, S., Donny, O., Fransisca, Julian, L.S., Ni N. J., Marcel R., “Artikel Penelitian Faktor-Faktor yang berhubungan dengan Keberhasilan Terapi GERD”, Journal Kedokteran Meditek, 2019.
[14] Ikatan Apoteker Indonesia, ISO Informasi Spesialite Obat Indonesia, Volume 52, Jakarta: PTISFI Penerbitan, 2019.
[15] BNF, British National Formulary 84th Edition, London: BMJ Publishing Group, 2023.
[16] Surya, H., “Tatalaksana Gastroesofageal Reflux Disease (GERD) dalam Masa Pandemi COVID-19”, Medicinus, vol. 33, no. 3, pp. 74–80, 2020.
[17] Pulungan, R., Chan, A., Fransiska, E., “Evaluasi Penggunaan Obat Rasional di Puskesmas Kabupaten Serdang Bedagai”, Jurnal Dunia Farmasi, 2019.
[18] Patala, R., Tandi, J., Ulzmi, U., Fahruddin. “Rasionalitas Penggunanaan Obat pada Pasien GERD di Instalasi Rawat Inap Rumah Sakit Umum Anutapura Palu”, JPSCR: Journal of Pharmaceutical Science and Clinical Research, 2021.
[19] Naomi, D.A. “Obesity as Risk Factor of Gastroesophageal Reflux Disease”, Refluks Gastroesofageal Journal MAJORITY, vol. 13, no. 7, 2014.
[20] Hafizh, S. M., Debi, M. L., “Hubungan Gastroesophageal Reflux Disease dengan Kualitas Tidur pada Mahasiswa Fakultas Kedokteran Universitas Muhammadiyah Sumatera Utara”, Jurnal Ilmiah MAKSITEK, vol. 6, No. 2, 2021.
Published
2025-02-22
How to Cite
WardaniatiI., & ZulianaD. (2025). Evaluation of Drug Use in Gastroesophageal Reflux Disease (GERD) Patient at the Outpatient Installation. JPK : Jurnal Proteksi Kesehatan, 13(2), 270-278. https://doi.org/10.36929/jpk.v13i2.1073
Section
Articles
